LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-08-27
Case ID: NM_000546.6_c.820G_T_20260827_182110
Framework: ACMG/AMP 2015
Variant classification summary

NM_000546.6:c.820G>T

TP53  · NP_000537.3:p.(Val274Phe)  · NM_000546.6
GRCh37: chr17:7577118 C>A  ·  GRCh38: chr17:7673800 C>A
Gene: TP53 Transcript: NM_000546.6
Final call
Likely Pathogenic
PS3 strong PM2 supporting PP3 supporting
All criteria require review: For research and educational purposes only.
Gene
TP53
Transcript
NM_000546.6
Protein
NP_000537.3:p.(Val274Phe)
gnomAD AF
6.195418364211298e-07 (v4.1)
ClinVar
Pathogenic
OncoKB
Likely Oncogenic
Interpretation summary
Generated evidence synthesis
1
PS3 (Strong): non-functional in the Kato assay and loss-of-function in the Funk, Giacomelli, and Kotler assays per the TP53 VCEP functional worksheet.
2
PM2 (Supporting): essentially absent from population databases, with gnomAD v4.1 total allele frequency 6.2e-07, below the 0.00003 threshold.
3
PP3 (Supporting): the VCEP per-variant table assigns PP3 on Align-GVGD class C45 and BayesDel 0.315825.
4
Overall: Likely Pathogenic, from PS3 strong (+4) + PM2 supporting (+1) + PP3 supporting (+1) = 6 points in the TP53 VCEP v2.4 framework.
Final determination: Under the TP53 VCEP v2.4 point-based framework, a total of 6 points maps to Likely Pathogenic.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 Not met Not met: missense change with no premature stop, frameshift, or splice effect (SpliceAI max delta 0.00).
cspec spliceai
PS1 Not assessed Not assessed: no previously established pathogenic or likely pathogenic variant producing the same p.Val274Phe change is available.
cspec pm5_candidates spliceai
PS2 Not assessed Not assessed: no confirmed de novo observation with parental testing and maternity/paternity confirmation was available.
cspec PMID:31775759
PS3 Met Met (Strong): non-functional in the Kato assay and loss-of-function in the Funk, Giacomelli, and Kotler assays per the VCEP worksheet.
cspec vcep_flowchart_for_application_of_functional_rule_codes vcep_functional_worksheet
PS4 Not assessed Not assessed: no qualifying germline proband observations; the only variant report is tumor-only.
cspec
PM1 Not assessed Not assessed: residue 274 is outside the VCEP PM1 codon list (175, 245, 248, 249, 273, 282).
cspec
PM2 Met Met (Supporting): gnomAD v4.1 total allele frequency 6.2e-07 (1/1,614,096 alleles), below the 0.00003 threshold.
cspec gnomad_v4 gnomad_v2 gnomad_canada
PM3 N/A Not applicable: PM3 does not apply to TP53, which the VCEP treats as an autosomal dominant disorder.
cspec
PM4 N/A Not applicable: missense substitution with no protein-length change.
cspec
PM5 Not assessed Not assessed: no different pathogenic or likely pathogenic missense variant at residue 274 is available as a comparator.
cspec pm5_candidates spliceai
PM6 N/A Not applicable: PM6 is dropped under the TP53 VCEP; de novo evidence is scored exclusively by PS2.
cspec
PP1 Not assessed Not assessed: no affected relatives or countable meioses in families with LFS-associated cancers were available.
cspec PMID:31775759
PP2 N/A Not applicable: PP2 is not permitted for TP53 under the VCEP specifications.
cspec
PP3 Met Met (Supporting): the VCEP per-variant table assigns PP3 based on Align-GVGD class C45 and BayesDel 0.315825.
cspec vcep_pp3_bp4_codes spliceai
PP4 Not assessed Not assessed: no multigene-panel tumor VAF observations (supporting requires 5-35%) were available.
cspec
PP5 Not met Not met: no exact-variant ClinVar expert-panel Pathogenic or Likely Pathogenic assertion is present.
clinvar
BA1 Not met Not met: highest ancestry allele frequency 8.5e-07 versus the >=0.001 BA1 threshold.
cspec gnomad_v4
BS1 Not met Not met: highest ancestry allele frequency 8.5e-07 versus the >=0.0003 BS1 threshold.
cspec gnomad_v4
BS2 Not assessed Not assessed: no qualifying carrier observations (unrelated females aged 60+ without cancer) were available.
cspec gnomad_v4
BS3 Not met Not met: the VCEP worksheet records loss-of-function results for V274F, not the functional pattern BS3 requires.
cspec vcep_flowchart_for_application_of_functional_rule_codes vcep_functional_worksheet
BS4 Not assessed Not assessed: no family genotypes or segregation data were available to evaluate lack of segregation.
cspec PMID:31775759
BP1 N/A Not applicable: p.Val274Phe is a missense variant, and BP1 applies only to truncating variants.
cspec
BP2 N/A Not applicable: BP2 is not an applicable TP53 VCEP criterion.
cspec
BP3 N/A Not applicable: missense substitution, not an in-frame insertion or deletion.
cspec
BP4 Not met Not met: the VCEP assigns pathogenic-direction PP3, not BP4, to this missense variant.
cspec vcep_pp3_bp4_codes spliceai
BP5 N/A Not applicable: BP5 is not applicable under the TP53 VCEP v2.4 specifications.
cspec
BP6 Not met Not met: no exact-variant ClinVar expert-panel Benign or Likely Benign assertion is present.
clinvar
BP7 N/A Not applicable: missense variant, not synonymous or intronic.
cspec
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.